TORL rakes in $158m for ADCs, and other bio financings
pharmaphorum
APRIL 12, 2024
Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
pharmaphorum
APRIL 12, 2024
Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.
pharmaphorum
MARCH 22, 2024
It has been a bumper week for biotech financings, with a $400m Series A for Mirador heading, topping impressive rounds for Capstan, Clasp, Engrail, Enliven, and Nouscom.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 5, 2024
Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight-loss category, alongside a trio of big private rounds.
pharmaphorum
FEBRUARY 16, 2024
Recent biotech financings include a $245m raise for cancer blood test company Freenome, plus big rounds for Cogent Biosciences, BioAge Labs, Latigo Biotherapeutics, ProfoundBio, and Firefly Bio
STAT
FEBRUARY 29, 2024
Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million. Continue to STAT+ to read the full story…
Drug Topics
APRIL 5, 2023
Members of the Senate Finance Committee are pushing PBMs to modernize the rules regarding out of pocket costs and competition.
pharmaphorum
JANUARY 25, 2024
Our latest crop of biotech financings features rounds for Synnovation Therapeutics and Adicet Bio, Calluna Pharma, Accent Therapeutics, GenEdit and IMU Bio
pharmaphorum
JANUARY 18, 2024
BridgeBioPharma raises $1.25bn to support acoramidis rollout and trials, plus other biotech financings for Tr1X, Comanche, Ratio, and Myrobalan
pharmaphorum
FEBRUARY 2, 2024
Our round-up of recent biotech financings is headed by a $250 million public offering for late clinical-stage biotech Vera Therapeutics, with an initial public offering (IPO) filed by CAR-T specialist Kyverna and private rounds for Eyconis, COUR Pharmaceuticals, Basking Biosciences, Enterprise Therapeutics, Halia Therapeutics and NeoPhore.
STAT
OCTOBER 18, 2023
Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers. Older adults at times have more than 100 plan options, and brokers help them choose the right one.
pharmaphorum
JANUARY 25, 2024
UK biotech shows "resilience" in 2023, raising £1.8bn despite lacklustre global financing market, says BIA
pharmaphorum
SEPTEMBER 7, 2023
Inceptive raises $100m, plus other digital financings Phil.Taylor Thu, 07/09/2023 - 11:02 Bookmark this
pharmaphorum
OCTOBER 18, 2023
Evident Vascular raises $35m, and other digital financings Phil.Taylor Wed, 18/10/2023 - 16:12 Bookmark this
pharmaphorum
NOVEMBER 15, 2023
Elucid’s $80m round heads latest digital health financings Phil.Taylor Wed, 15/11/2023 - 08:17 Bookmark this
pharmaphorum
DECEMBER 14, 2023
Twin Health raises $50m, and other digital health financings Phil.Taylor Thu, 14/12/2023 - 19:11 Bookmark this
Pharmaceutical Technology
NOVEMBER 28, 2023
Venture financing for innovative radiopharmaceutical drugs witnessed an approximately 550% increase from $63m in 2017 to $408m in 2023 YTD (year-to-date) total deal value in the US.
pharmaphorum
SEPTEMBER 15, 2023
Double IPOs headline this week's biotech financings Phil.Taylor Fri, 15/09/2023 - 09:30 Bookmark this
Fierce Pharma
OCTOBER 2, 2023
Amicus unveiled a $430 million financing pact with Blackstone Life Sciences and Blackstone Credit. Hot off an FDA approval for its Pompe disease combo treatment, Amicus Therapeutics has reeled in a major investor.
Drug Topics
APRIL 22, 2024
According to Scott Soefje, PharmD, understanding nuances across sites of care can help health care providers optimize patient care delivery while ensuring financial viability across all settings.
Drug Topics
NOVEMBER 1, 2022
Pharmacy finances can suffer if owners are tripped up by these common pitfalls.
pharmaphorum
SEPTEMBER 8, 2023
Apollo, Nimbus lead bumper week for biotech financings Phil.Taylor Fri, 08/09/2023 - 11:14 Bookmark this
pharmaphorum
OCTOBER 14, 2022
has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The Series B financing includes participation from all Series A investors and new investment from Fidelity Management & Research Company and T. Biotech company Odyssey Therapeutics, Inc.
pharmaphorum
SEPTEMBER 5, 2023
Novartis updates on Sandoz finances ahead of spin-off Phil.Taylor Tue, 05/09/2023 - 11:16 Bookmark this
STAT
APRIL 9, 2024
The numbers are in, and biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past. Venture-backed biopharma companies raised $6.8 billion in the first three months of the year, according to early data compiled by HSBC.
pharmaphorum
JULY 27, 2023
Headspace raise leads flurry of digital health financings Phil.Taylor Thu, 27/07/2023 - 18:35 Bookmark this
Fierce Healthcare
JULY 26, 2023
In a largely harmonious Senate Committee on Finance markup hearing, members supported bipartisan efforts to rein in pharmacy benefit managers (PBMs) that they say operate without transparency to dr | The Senate wants to improve transparency surrounding pharmacy benefit managers and bring down prescription drug prices for the average person.
pharmaphorum
SEPTEMBER 1, 2023
Nursa's $80m raise leads recent digital health financings Phil.Taylor Fri, 01/09/2023 - 07:50 Bookmark this
pharmaphorum
APRIL 6, 2022
2021 was a big year in investment financing for US digital health companies, but there are signs that it may be a high watermark. The strength of the late-stage private financing sector may reflect the challenges affecting the public markets, says Rock Health. The post Digital health financing bonanza slows in Q1 appeared first on.
Fierce Healthcare
JULY 26, 2023
Digital mental health company Headspace secured $105 million in new debt financing as it eyes opportunities to expand its business with employers and health plans.
DiversifyRx
OCTOBER 27, 2022
Recently we put up a poll on our LinkedIn and Facebook pages, asking pharmacy owners if they were interested in learning about financing working capital. I love to talk about cash flow, finances, numbers, and all those nitty-gritty things that most people hate to discuss. Financing Options for Working Capital.
Outsourcing Pharma
AUGUST 24, 2023
FORE Biotherapeutics yesterday (August 23) announced the closing of its $75 million (Â59 million) series D financing, led by the SR One and co-led by Medicxi and joined by existing investors.
Pharmafile
SEPTEMBER 28, 2023
US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue its portfolio of inhalation therapies. While systemic […] The post Avalyn Pharma raises $175m in Series C financing for inhalation therapies appeared first on Pharmafile.
pharmaphorum
JULY 6, 2021
billion) in financing in the three months to end-May – which is a record for the industry. Oxford Nanopore is also building up to an initial public offering (IPO) later this year that could reinforce 2021’s position as the best-ever year for UK financing, well ahead of last year’s total tally of £2.81 billion ($2.2
pharmaphorum
OCTOBER 5, 2022
After a bumper 2021, the fall-off in digital health financing deals that started to appear early this year has continued, with the three month to send September the lowest funded quarter since the tail end of 2019. ” The post Digital health financing drops again, but don’t worry yet appeared first on.
Fierce Healthcare
MARCH 24, 2023
AHA: MedPAC report on hospital finances 'misleading;' recommended 2024 pay bump 'totally insufficient' dmuoio Fri, 03/24/2023 - 15:39
STAT
JULY 26, 2023
The country’s largest private psychiatric hospital operator cherry-picks patients whose insurance will pay more, its finance chief said on an earnings call Wednesday.
pharmaphorum
OCTOBER 17, 2023
Nucleus RadioPharma raises $56m in first round financing Phil.Taylor Tue, 17/10/2023 - 17:51 Bookmark this
Pharmafile
APRIL 14, 2023
Irish medical device company Neuromod has announced that it has successfully closed a €30m financing intended to further commercialise Lenire, its tinnitus treatment device. This financing follows the FDA granting de novo approval for the device. read more
pharmaphorum
OCTOBER 12, 2023
Agomab raises $100m for Crohn’s drug, and other financings Phil.Taylor Thu, 12/10/2023 - 11:07 Bookmark this
Fierce Healthcare
MAY 25, 2023
Providers weigh AI solutions as nursing shortage dings finances: Kaufman Hall fdiamond Thu, 05/25/2023 - 13:24
Pharmaceutical Commerce
NOVEMBER 3, 2023
Study describes how biotech startups can avoid competing with large pharma companies for financing.
Pharmaceutical Technology
NOVEMBER 7, 2023
At the BIO-Europe conference, experts said smaller oncology biotechs need to explore alternate financing strategies for pipeline development.
pharmaphorum
MARCH 15, 2024
Our latest round-up of funding rounds in the digital health category features updates from Healthee, Aktiia, Moxe Health, Eleanor Health, Tava Health, BrainCheck, and Redi Health.
Pharmaceutical Technology
MARCH 1, 2023
Venture financing for early-stage innovator drugs for biotech companies based in the Asia-Pacific (APAC) region between 2018 to 2022 received three times less funding, at $23bn, than their US counterparts, at $72bn, according to GlobalData’s Pharma Intelligence Centre Deals Database. Hangzhou DAC Biotech, based in China, raised $155.4m
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content